Related Experiment Video
Updated: May 3, 2026
Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
Published on: December 19, 2025
Evidence for the importance of personalized molecular profiling in pancreatic cancer
Loukia N Lili1, Lilya V Matyunina, L DeEtte Walker
1From the *Integrated Cancer Research Center, School of Biology, and Parker H. Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta; and †Cancer Treatment Centers of America SE Regional Facility, Newnan, GA.
Objectives:
There is a growing body of evidence that targeted gene therapy holds great promise for the future treatment of cancer. A crucial step in this therapy is the accurate identification of appropriate candidate genes/pathways for targeted treatment. One approach is to identify variant genes/pathways that are significantly enriched in groups of afflicted individuals relative to control subjects. However, if there are multiple molecular pathways to the same cancer, the molecular determinants of the disease may be heterogeneous among individuals and possibly go undetected by group analyses.
Methods:
In an effort to explore this question in pancreatic cancer, we compared the most significantly differentially expressed genes/pathways between cancer and control patient samples as determined by group versus personalized analyses.
Results:
We found little to no overlap between genes/pathways identified by gene expression profiling using group analyses relative to those identified by personalized analyses.
Conclusions:
Our results indicate that personalized and not group molecular profiling is the most appropriate approach for the identification of putative candidates for targeted gene therapy of pancreatic and perhaps other cancers with heterogeneous molecular etiology.
Insights
Personalized gene profiling is crucial for identifying cancer treatment targets. Group analyses miss key molecular differences in heterogeneous cancers like pancreatic cancer, highlighting the need for individualized approaches in gene therapy development.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Targeted gene therapy shows promise for cancer treatment.
- Accurate identification of candidate genes/pathways is essential.
- Cancer molecular profiles can be heterogeneous, challenging group-based analyses.
Purpose of the Study:
- To compare group versus personalized analyses for identifying differentially expressed genes/pathways in pancreatic cancer.
- To assess the efficacy of personalized molecular profiling for targeted gene therapy candidate identification.
Main Methods:
- Differential gene expression profiling was performed on pancreatic cancer and control samples.
- Analyses were conducted using both group-based and personalized approaches.
- Comparison of identified genes/pathways between the two analytical methods.
Main Results:
- Little to no overlap was observed between genes/pathways identified by group analyses and personalized analyses.
- Personalized analyses revealed distinct molecular signatures compared to group analyses.
Conclusions:
- Personalized molecular profiling is superior to group analyses for identifying potential gene therapy targets in heterogeneous cancers.
- Individualized approaches are necessary for effective targeted gene therapy in pancreatic and potentially other cancers.
- Heterogeneity in cancer etiology necessitates personalized strategies for optimal treatment selection.
